JPWO2022255349A1 - - Google Patents
Info
- Publication number
- JPWO2022255349A1 JPWO2022255349A1 JP2023525850A JP2023525850A JPWO2022255349A1 JP WO2022255349 A1 JPWO2022255349 A1 JP WO2022255349A1 JP 2023525850 A JP2023525850 A JP 2023525850A JP 2023525850 A JP2023525850 A JP 2023525850A JP WO2022255349 A1 JPWO2022255349 A1 JP WO2022255349A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021091607 | 2021-05-31 | ||
PCT/JP2022/022077 WO2022255349A1 (ja) | 2021-05-31 | 2022-05-31 | 可溶型clec2を用いた出血性脳卒中のリスク評価法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2022255349A1 true JPWO2022255349A1 (ja) | 2022-12-08 |
Family
ID=84323410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023525850A Pending JPWO2022255349A1 (ja) | 2021-05-31 | 2022-05-31 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20240264175A1 (ja) |
EP (1) | EP4350350A1 (ja) |
JP (1) | JPWO2022255349A1 (ja) |
KR (1) | KR20240017001A (ja) |
CN (1) | CN117769652A (ja) |
WO (1) | WO2022255349A1 (ja) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6078845U (ja) | 1983-11-04 | 1985-06-01 | ライオン株式会社 | 食用廃油固化処理用具 |
AU2002359815A1 (en) * | 2001-12-19 | 2003-07-09 | Immunex Corporation | C-type lectin polypeptide, polynucleotide and methods of making and use thereof |
JP6078845B2 (ja) * | 2012-09-28 | 2017-02-15 | 株式会社Lsiメディエンス | 可溶型clec−2に基づく血小板活性化測定方法 |
WO2015053381A1 (ja) * | 2013-10-10 | 2015-04-16 | 幸成 加藤 | 抗ポドプラニン抗体 |
JP7172286B2 (ja) | 2018-08-28 | 2022-11-16 | スズキ株式会社 | ニーエアバッグ取付け構造 |
JP6883348B2 (ja) | 2019-06-26 | 2021-06-09 | 稔 甲斐 | 閉塞防止機能付振動篩用網及び振動篩装置 |
KR20220147624A (ko) * | 2020-02-28 | 2022-11-03 | 가부시키가이샤 엘에스아이 메디엔스 | 가용성 clec-2와 혈소판 수에 기초한 혈소판 활성화 측정 방법 |
-
2022
- 2022-05-31 EP EP22816095.8A patent/EP4350350A1/en active Pending
- 2022-05-31 JP JP2023525850A patent/JPWO2022255349A1/ja active Pending
- 2022-05-31 WO PCT/JP2022/022077 patent/WO2022255349A1/ja active Application Filing
- 2022-05-31 US US18/565,258 patent/US20240264175A1/en active Pending
- 2022-05-31 KR KR1020237044828A patent/KR20240017001A/ko unknown
- 2022-05-31 CN CN202280038986.4A patent/CN117769652A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20240264175A1 (en) | 2024-08-08 |
EP4350350A1 (en) | 2024-04-10 |
KR20240017001A (ko) | 2024-02-06 |
CN117769652A (zh) | 2024-03-26 |
WO2022255349A1 (ja) | 2022-12-08 |